SIMPLICEF DIN 02397994
Status: Approved
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | CEFPODOXIME (CEFPODOXIME PROXETIL) 100 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | |
|---|
| Current status date | 10-Feb-2014 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEFPODOXIME (CEFPODOXIME PROXETIL)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02398001 | SIMPLICEF | ZOETIS CANADA INC | Tablet | CEFPODOXIME (CEFPODOXIME PROXETIL) 200 MG | Marketed |
| 02226847 | ORELOX | SANOFI-AVENTIS CANADA INC | Tablet | CEFPODOXIME (CEFPODOXIME PROXETIL) 100 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 15220 | 2014-02-10 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 13924 | 2012-12-06 | New Drug Submission (NDS) | |
Request a quote for SIMPLICEF
How to read a Canadian DIN record